Vesper Bio awarded grant by The Michael J. Fox Foundation to assess sortilin inhibitors in the treatment of Parkinson's disease

Vesper Bio United Kingdom United States of America Denmark New York

View original content:https://www.prnewswire.co.uk/news-releases/vesper-bio-awarded-grant-by-the-michael-j-fox-foundation-to-assess-sortilin-inhibitors-in-the-treatment-of-parkinsons-disease-302040660.html